AnaptysBio Statistics
NASDAQ: ANABHealthcareBiotechnologyUSD
45.65-2.24 (-4.68%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AnaptysBio by the numbers
AnaptysBio has a market capitalization of $1.36 billion based on 29.90M shares outstanding. With trailing EPS of $-0.91, AnaptysBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.7% below its 50-day average and 6.8% below its 200-day average.
Average daily trading volume is 569.55K shares, or about $26.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANAB valuation vs. peer median
| Metric | ANAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.36B | $1.37B | -0% |
| Avg. volume | 569.55K | 706.20K | -19% |
Peer median across 8 companies: KLRA, OMER, INBX, NKTR, COAG, AAPG, TYRA, DRTS.
Valuation
- Market cap
- $1.36B
- Forward P/E
- 9.01
- EPS (TTM)
- $-0.91
- Shares outstanding
- 29.90M
Price and trading
- Previous close
- 47.89
- Open
- 47.00
- Day range
- 45.62 – 47.39
- 52-week range
- 20.18 – 72.36
- 52-week change
- +129.24%
- Beta
- —
- Volume
- 766.53K
- Average volume
- 569.55K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 1.36B
- Forward Pe
- 9.01
- Eps
- -0.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 72.36
- Week52 Low
- 20.18
- Avg Volume
- 569.55K
- Shares Outstanding
- 29.90M
- Ma50
- 54.77
- Ma200
- 48.98
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -36.91%
- Pct From52w Low
- 126.21%